Galmed Pharmaceuticals Announces Closing of Initial Public Offering and Full Exercise of

TEL AVIV, Israel, March 18, 2014 /PRNewswire/ — Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) ("Galmed") today announced the closing of its